Latent Genetic Architecture of Parkinson’s Disease Risk factors and Comorbidities
Objective: To comprehensively investigate the genetic relationship between Parkinson’s disease (PD), its risk factors, and comorbidities by constructing a factor model of the shared genetic…Clinico-genetic profile of five patients with PARK-PINK1: A case series from India
Objective: The aim of our study is to describe the clinical features and genetic profile of patients of PARK-PINK1 and to draw correlation with genetic…The association of Severity and Monogenetic Subgroups in Parkinson’s Disease
Objective: Explore how different genotypes can affect the disease severity and progression in Parkinson's patients. Background: Genetic advances have identified specific mutations linked to disease…Hemochromatosis and Movement Disorders
Objective: To describe a series (clinical and imaging) of movement disorders occurring in patients with hemochromatosis Background: Hemochromatosis is a frequent disease, characterized by deposits…Movement Disorders in Cerebrotendinous Xanthomatosis
Objective: To report the type of movement disorders, Neuroimaging, and prognosis in nine adult patients with neurological CTX. Background: Cerebrotendinous Xanthomatosis (CTX) is a lipid…Complexity of fractal patterns in motor cortical oscillatory activity in rodent models of Parkinson disease
Objective: To investigate whether motor cortical oscillation changes in fractal patterns are associated with a change in the FD in the HALO and the 6-OHDA…Personalized Optimization of Deep Brain Stimulation Parameters for Gait Enhancement in Parkinson’s Disease: A Data-Driven Approach
Objective: Our goal is to develop a data-driven approach to identify optimal Deep brain stimulation (DBS) parameters for gait enhancement in patients with Parkinson's disease…Quantitative Analysis of the Biomechanical Contributors during the miniBEST Clinical Scale for Assessing Risk of Falling in Parkinson’s Disease
Objective: The objective of this study was to determine the most relevant biomechanical factors contributing to the risk of falling in those with Parkinson’s Disease…Altered gut microbiota composition and metabolism in Parkinson’s disease
Objective: To define changes in gut microbiota composition and metabolism to enable identification of novel therapeutic targets and strategies for disease modification. Background: Multiple cohort…Muscle Augmentation Paradox: Contrasting Therapeutic Approaches in Myasthenia Gravis and Parkinson’s Disease
Objective: This exploration aims to dissect the therapeutic paradox presented by muscle augmentation strategies in Myasthenia Gravis (MG) and Parkinson's Disease (PD), offering a comparative…
- « Previous Page
- 1
- …
- 65
- 66
- 67
- 68
- 69
- …
- 181
- Next Page »